106 related articles for article (PubMed ID: 38718047)
1. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan.
Ando K; Shimomura A; Watanabe K; Tsukada K; Teruya K; Gatanaga H; Shimizu C
Cancer; 2024 May; ():. PubMed ID: 38718047
[TBL] [Abstract][Full Text] [Related]
2. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
[TBL] [Abstract][Full Text] [Related]
3. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
[TBL] [Abstract][Full Text] [Related]
4. [Current Topics of Cancer and HIV].
Tanaka M; Ajisawa A
Gan To Kagaku Ryoho; 2020 May; 47(5):754-757. PubMed ID: 32408313
[TBL] [Abstract][Full Text] [Related]
5. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
6. Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
Chammartin F; Mocroft A; Egle A; Zangerle R; Smith C; Mussini C; Wit F; Vehreschild JJ; d'Arminio Monforte A; Castagna A; Bailly L; Bogner J; de Wit S; Matulionyte R; Law M; Svedhem V; Tallada J; Garges HP; Marongiu A; Borges ÁH; Jaschinski N; Neesgaard B; Ryom L; Bucher HC;
Clin Infect Dis; 2024 Apr; 78(4):995-1004. PubMed ID: 38092042
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
8. Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS).
Bendle M; Pealing J; Papanastasopoulos P; Bower M
Cancer Chemother Pharmacol; 2014 Sep; 74(3):611-5. PubMed ID: 25055936
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan.
Katano H; Hishima T; Mochizuki M; Kodama Y; Oyaizu N; Ota Y; Mine S; Igari T; Ajisawa A; Teruya K; Tanuma J; Kikuchi Y; Uehira T; Shirasaka T; Koibuchi T; Iwamoto A; Oka S; Hasegawa H; Okada S; Yasuoka A
BMC Infect Dis; 2014 Apr; 14():229. PubMed ID: 24775713
[TBL] [Abstract][Full Text] [Related]
10. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
11. Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.
Trickey A; May MT; Gill MJ; Grabar S; Vehreschild J; Wit FWNM; Bonnet F; Cavassini M; Abgrall S; Berenguer J; Wyen C; Reiss P; Grabmeier-Pfistershammer K; Guest JL; Shepherd L; Teira R; d'Arminio Monforte A; Del Amo J; Justice A; Costagliola D; Sterne JAC
Int J Cancer; 2020 Jun; 146(11):3134-3146. PubMed ID: 32003460
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities and co-medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan.
Naito T; Suzuki M; Fukushima S; Yuda M; Fukui N; Tsukamoto S; Fujibayashi K; Goto-Hirano K; Kuwatsuru R
HIV Med; 2022 May; 23(5):485-493. PubMed ID: 34821006
[TBL] [Abstract][Full Text] [Related]
13. Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era.
Nguyen ML; Farrell KJ; Gunthel CJ
Curr Infect Dis Rep; 2010 Jan; 12(1):46-55. PubMed ID: 21308498
[TBL] [Abstract][Full Text] [Related]
14. Changes in survival and causes of death among people living with HIV: Three decades of surveys from Tokyo, one of the Asian metropolitan cities.
Tsuda H; Koga M; Nojima M; Senkoji T; Kubota M; Kikuchi T; Adachi E; Ikeuchi K; Tsutsumi T; Koibuchi T; Yotsuyanagi H
J Infect Chemother; 2021 Jul; 27(7):949-956. PubMed ID: 33663931
[TBL] [Abstract][Full Text] [Related]
15. Non-AIDS-defining malignancies in Japanese hemophiliacs with HIV-1 infection.
Oka S; Ogata M; Takano M; Minamimoto R; Hotta M; Tajima T; Nagata N; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H;
Glob Health Med; 2019 Oct; 1(1):49-54. PubMed ID: 33330754
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and trend of AIDS-defining cancers and non-AIDS-defining cancers and their association with antiretroviral therapy among people living with HIV in South Carolina: a population-based cohort study.
Nkwonta CA; Zhang J; Chen S; Weissman S; Olatosi B; Li X
AIDS Care; 2023 May; 35(5):753-763. PubMed ID: 35578401
[No Abstract] [Full Text] [Related]
17. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
Elizabeth C
AIDS; 2021 Oct; 35(12):1973-1985. PubMed ID: 34049355
[TBL] [Abstract][Full Text] [Related]
18. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
19. The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review.
Pumpalova YS; Segall L; Felli R; Bhatkhande G; Jacobson JS; Neugut AI
Semin Oncol; 2021 Jun; 48(3):226-235. PubMed ID: 34593219
[TBL] [Abstract][Full Text] [Related]
20. [HIV infection and non-AIDS-defining malignancies: an outpatient clinic experience].
Fevereiro Mdo C
Acta Med Port; 2014; 27(2):181-90. PubMed ID: 24813485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
